Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Gore

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
Molecular Cancer Therapeutics|November 9, 2005
Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshopArthur Zelent, Kevin Petrie, Reuben Lotan, et al.
Current Opinion in Hematology|January 12, 2019
What are the most promising new agents in myelodysplastic syndromes?Namrata S Chandhok, Prajwal C Boddu, Steven D Gore, et al.
Blood Reviews|June 30, 2015
The evolving field of prognostication and risk stratification in MDS: Recent developments and future directionsEun-Ju Lee, Nikolai Podoltsev, Steven D Gore, et al.
Blood Reviews|October 18, 2016
Selecting initial treatment of acute myeloid leukaemia in older adultsNikolai A Podoltsev, Maximilian Stahl, Amer M Zeidan, et al.
Current Opinion in Hematology|January 10, 2015
Current state of prognostication and risk stratification in myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Eric Padron, et al.
The American Journal of Medicine|March 20, 2013
Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS)Amer M Zeidan, B Douglas Smith, Rami S Komrokji, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Myelodysplastic syndromeGhulam Mufti, Alan F List, Steven D Gore, et al.
Blood Reviews|September 29, 2020
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midstRory M Shallis, Julian J Weiss, Nicole C Deziel, et al.
Blood Reviews|August 11, 2020
A clandestine culprit with critical consequences: Benzene and acute myeloid leukemiaRory M Shallis, Julian J Weiss, Nicole C Deziel, et al.
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
Molecular Cancer Therapeutics|November 9, 2005
Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshopArthur Zelent, Kevin Petrie, Reuben Lotan, et al.
Current Opinion in Hematology|January 12, 2019
What are the most promising new agents in myelodysplastic syndromes?Namrata S Chandhok, Prajwal C Boddu, Steven D Gore, et al.
Blood Reviews|June 30, 2015
The evolving field of prognostication and risk stratification in MDS: Recent developments and future directionsEun-Ju Lee, Nikolai Podoltsev, Steven D Gore, et al.
Blood Reviews|October 18, 2016
Selecting initial treatment of acute myeloid leukaemia in older adultsNikolai A Podoltsev, Maximilian Stahl, Amer M Zeidan, et al.
Current Opinion in Hematology|January 10, 2015
Current state of prognostication and risk stratification in myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Eric Padron, et al.
The American Journal of Medicine|March 20, 2013
Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS)Amer M Zeidan, B Douglas Smith, Rami S Komrokji, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Myelodysplastic syndromeGhulam Mufti, Alan F List, Steven D Gore, et al.
Blood Reviews|September 29, 2020
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midstRory M Shallis, Julian J Weiss, Nicole C Deziel, et al.
Blood Reviews|August 11, 2020
A clandestine culprit with critical consequences: Benzene and acute myeloid leukemiaRory M Shallis, Julian J Weiss, Nicole C Deziel, et al.
Pageof 22